A proactive approach to managing glaucoma
iDose® TR is part of a shift toward proactive care designed to help reduce the daily challenges of prescription eye drops. Learn more about this interventional glaucoma treatment before your next eye appointment.
What is iDose® TR?
iDose® TR is the only FDA‑approved fixed implant designed to continuously deliver medication inside the eye to help lower eye pressure in people with open‑angle glaucoma or ocular hypertension.
With iDose® TR, you get the prescription medication your eye needs, without the inconvenience of prescription eye drops or challenges of putting them in the eye.
In clinical studies, the most common side effects of iDose TR (occurring in 6% or fewer people) were increased eye pressure, inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness, and reduced vision. 8 out of 10 people were completely free of prescription eye drops at 12 months with iDose TR.
Why proactive care matters
Many patients understand the importance of managing eye pressure but struggle with daily treatment routines. A proactive approach earlier in the treatment journey aims to help address these challenges.
- 24/7 Therapy
- 0 Missed Doses
- Long-term IOP Control
Do you have an upcoming eye appointment?
Enter your email to get instant access to our guide that will help you better understand proactive glaucoma care and prepare for a conversation with your doctor.
Discussion Guide Download
"*" indicates required fields
This guide will help you reflect on:
How glaucoma management is changing
What proactive care means
How iDose TR fits into a modern treatment approach
Tips for talking with your eye doctor
Important Safety Information
iDose TR is gently placed directly inside your eye by your eye doctor.
You should not have iDose TR if you have an infection or suspected infection in your eye or the area surrounding your eye, have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally as this can cause vision problems, have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant), are allergic to any of its ingredients, and/or have narrow angles (the iris and the cornea are too close together).
The most common side effect of iDose TR was increased eye pressure. Other common side effects were inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness and reduced clearness of vision.
If you have additional questions, please contact your doctor. For full Prescribing Information click here.
Approved Uses
iDose TR (travoprost intracameral implant) is a prescription medicine and drug delivery system for the eye approved to lower eye pressure in patients with open-angle glaucoma or high eye pressure (ocular hypertension).
You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also call Glaukos at 1-855-918-1504.